These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5922147)

  • 21. Pharmacologic studies with 3-(phenylpropoxy)guanidine cyclohexanesulfamate.
    Veldkamp W; Keasling HH; Johnson GA; Freyburger WA; Collins RJ
    J Pharm Sci; 1967 Jul; 56(7):829-33. PubMed ID: 6034824
    [No Abstract]   [Full Text] [Related]  

  • 22. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of drugs on the biochemical and behavioral responses of developing organisms.
    Sparber SB
    Fed Proc; 1972; 31(1):74-80. PubMed ID: 5061895
    [No Abstract]   [Full Text] [Related]  

  • 24. Statistical correlations concerning electroencephalographic and behavioural effects of reserpine in cats during approach-avoidance successive differentiation.
    Psatta DM
    Rev Roum Neurol; 1973; 10(4):287-308. PubMed ID: 4767887
    [No Abstract]   [Full Text] [Related]  

  • 25. The concentration of 5-methoxytryptamine in rat brain and its effects on behaviour following its peripheral injection.
    Green AR; Hughes JP; Tordoff AF
    Neuropharmacology; 1975 Aug; 14(8):601-6. PubMed ID: 126386
    [No Abstract]   [Full Text] [Related]  

  • 26. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperactive states related to the metabolism of norepinephrine and similar biochemicals.
    Scheckel CL; Boff E; Pazery LM
    Ann N Y Acad Sci; 1969 Jul; 159(3):939-58. PubMed ID: 4981886
    [No Abstract]   [Full Text] [Related]  

  • 28. Some aspects of the behavior of young and adult rats treated with p-chlorophenylalanine in infancy.
    Adlard BP; Smart JL
    Dev Psychobiol; 1974 Mar; 7(2):135-44. PubMed ID: 4362763
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of the role of noradrenaline in behavioral changes produced in the rat by psychotomimetic drugs.
    Sugrue MF
    Br J Pharmacol; 1969 Feb; 35(2):243-52. PubMed ID: 5774043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7,N,N-Trimethyltryptamine: a selective inhibitor of synaptosomal serotonin uptake.
    Glennon RA; Martin B; Johnson KM; End D
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):161-4. PubMed ID: 625585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N; Hirsch A; Sulman FG
    Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of some drugs influencing brain monoamines on body temperature of albino rat.
    Singh PP; Bhattacharya SK; Bose R; Das PK
    Indian J Exp Biol; 1978 Sep; 16(9):995-7. PubMed ID: 721160
    [No Abstract]   [Full Text] [Related]  

  • 33. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
    Wallach MB; Friedman E; Gershon S
    J Pharmacol Exp Ther; 1972 Jul; 182(1):145-54. PubMed ID: 4261221
    [No Abstract]   [Full Text] [Related]  

  • 34. Some behavioral effects of Ditran (JB 329) in rats.
    Pradhan SN; Beer B; Roth T; Dutta SN
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):264-75. PubMed ID: 6076580
    [No Abstract]   [Full Text] [Related]  

  • 35. The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Mt Sinai J Med; 1974; 41(2):276-82. PubMed ID: 4544624
    [No Abstract]   [Full Text] [Related]  

  • 36. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
    Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
    Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
    [No Abstract]   [Full Text] [Related]  

  • 37. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 38. Serotonin deficiency in infancy as a cause of a mental defect in experimental phenylketonuria.
    Woolley DW; Van der Hoeven T
    Int J Neuropsychiatry; 1965 Dec; 1(6):529-44. PubMed ID: 5296216
    [No Abstract]   [Full Text] [Related]  

  • 39. Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.
    Andén NE; Corrodi H; Fuxe K
    J Pharmacol Exp Ther; 1971 Nov; 179(2):236-49. PubMed ID: 5133600
    [No Abstract]   [Full Text] [Related]  

  • 40. Transmitter role of serotonin in identified synapses in Aplysia nervous system.
    Paupardin-Tritsch D; Gerschenfeld HM
    Brain Res; 1973 Aug; 58(2):529-34. PubMed ID: 4356938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.